Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC) (vol 3, pg 256, 2021)

被引：0

作者：

Marchioni, Michele ^{[1
,2
]}

Kriegmair, Maximilian ^{[3
]}

Heck, Mathias ^{[4
]}

Amiel, Thomas ^{[4
]}

Porpiglia, Francesco ^{[5
]}

Checcucci, Enrico ^{[5
]}

Campi, Riccardo ^{[6
]}

Minervini, Andrea ^{[6
]}

Mari, Andrea ^{[6
]}

Van Bruwaene, Siska ^{[7
]}

Linares, Estefania ^{[8
]}

Hevia, Vital ^{[9
]}

Musquera, Mireia ^{[10
]}

D'Anna, Mauricio ^{[10
]}

Derweesh, Ithaar ^{[11
]}

Bradshaw, Aaron ^{[11
]}

Autorino, Riccardo ^{[12
,19
]}

Guruli, Georgi ^{[12
,19
]}

Veccia, Alessandro ^{[12
,19
]}

Roussel, Eduard ^{[13
]}

Albersen, Maarten ^{[13
]}

Pavan, Nicola ^{[14
]}

Claps, Francesco ^{[14
]}

Antonelli, Alessandro ^{[15
]}

Palumbo, Carlotta ^{[15
]}

Klatte, Tobias ^{[16
]}

Erdem, Selcuk ^{[17
]}

Mir, Maria Carmen ^{[18
]}

机构：

[1] Univ G dAnnunzio, Lab Biostat, Dept Med Oral & Biotechnol Sci, Chieti, Italy

[2] Univ G dAnnunzio, Dept Urol, SS Annunziata Hosp, Chieti, Italy

[3] Univ Med Ctr Mannheim, Dept Urol, Mannheim, Germany

[4] Tech Univ Munich, Dept Urol, Munich, Germany

[5] Univ Turin, San Luigi Gonzaga Hosp, Dept Urol, Sch Med, Turin, Italy

[6] Univ Florence, Careggi Hosp, Dept Urol, Florence, Italy

[7] AZ Groeninge, Dept Urol, Kortrijk, Belgium

[8] Hosp La Paz, Dept Urol, Madrid, Spain

[9] Hosp Ramon & Cajal, Dept Urol, Madrid, Spain

[10] Hosp Clin Barcelona, Dept Urol, Barcelona, Spain

[11] Univ Calif San Diego, Sch Med, Dept Urol, UC San Diego Moores Canc Ctr, Louisiana Jolla, CA USA

[12] VCU Med Ctr, Div Urol, Richmond, VA USA

[13] Univ Hosp Leuven, MDepartment Urol, Leuven, Belgium

[14] Univ Trieste, Dept Med Surg & Hlth Sci, Urol Clin, Trieste, Italy

[15] Univ Verona, AOUI Verona Hosp, Dept Urol, Verona, Italy

[16] Univ Hosp Dorset, Royal Bournemouth Hosp, Dept Urol, Bournemouth, Dorset, England

[17] Istanbul Univ, Dept Urol, Fac Med, Istanbul, Turkey

[18] Fdn Inst Valenciano Oncol, Dept Urol, Valencia, Spain

[19] VCU Med Ctr, Div Urol, Richmond, VA USA

来源：

EUROPEAN UROLOGY ONCOLOGY | 2021年 / 4卷 / 03期

关键词：

D O I：

10.1016/j.euo.2021.04.007

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：517 / 517

页数：1

共 3 条

[1] Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC)
Marchioni, Michele
Kriegmair, Maximilian
Heck, Mathias
Amiel, Thomas
Porpiglia, Francesco
Ceccucci, Enrico
Campi, Riccardo
Minervini, Andrea
Mari, Andrea
Van Bruwaene, Siska
Linares, Estefania
Hevia, Vital
Musquera, Mireia
D'Anna, Mauricio
Derweesh, Ithaar
Bradshaw, Aaron
Autorino, Riccardo
Guruli, Georgi
Veccia, Alessandro
Roussel, Eduard
Albersen, Maarten
Pavan, Nicola
Claps, Francesco
Antonelli, Alessandro
Palumbo, Carlotta
Klatte, Tobias
Erdem, Selcuk
Mir, Maria Carmen
EUROPEAN UROLOGY ONCOLOGY, 2021, 4 (02): : 256 - 263
[2] Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era - a multi-institutional retrospective study (vol 27, pg 563, 2022)
Kato, Renpei
Naito, Sei
Numakura, Kazuyuki
Hatakeyama, Shingo
Koguchi, Tomoyuki
Kojima, Takahiro
Kawasaki, Yoshihide
Kandori, Shuya
Kawamura, Sadafumi
Arai, Yoichi
Ito, Akihiro
Nishiyama, Hiroyuki
Kojima, Yoshiyuki
Ohyama, Chikara
Habuchi, Tomonori
Tsuchiya, Norihiko
Obara, Wataru
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2023, 28 (05) : 726 - 727
[3] Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study) (vol 13, pg 1, 2021)
Rebuzzi, S. E.
Signori, A.
Banna, G.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13

← 1 →